Revolution Medicines Eulerpool Nyheter

Revolution Medicines Aktiens nyheter

Revolution Medicines bevakas av många journalister och investerare över hela världen. De senaste Revolution Medicines nyheterna samlar vi här.

• 16 juli ·

  Yahoo
  Revolution Medicines (RVMD) Gets Initiated With a New Buy Rating at Goldman Sachs
• 9 juli ·

  Yahoo
  Revolution Medicines and Iambic Announce Technology and Research Collaboration Using Iambic’s AI Discovery Tools to Pursue New Drug Candidates
• 9 juli ·

  Yahoo
  Revolution Medicines’ Daraxonrasib Granted FDA Breakthrough Therapy Designation for Pancreatic Cancer with KRAS G12 Mutations
• 6 juli ·

  Yahoo
  Revolution Medicines, Summit Therapeutics Partner on RAS Inhibitor/Ivonescimab Combinations for Solid Tumors
• 2 juli ·

  Yahoo
  Oppenheimer Reaffirms Outperform on Revolution Medicines, Cites PDAC and NSCLC Trial Progress
• 24 juni ·

  Yahoo
  Revolution Medicines Signs $2 Billion Funding Deal With Royalty Pharma
• 24 juni ·

  Yahoo
  Revolution Medicines Enters Into $2 Billion Flexible Funding Agreement with Royalty Pharma to Support Global Development and Commercialization of RAS(ON) Inhibitor Portfolio for Patients with RAS-Addicted Cancers
• 23 juni ·

  Yahoo
  Sector Update: Health Care Stocks Mixed in Afternoon Trading
• 23 juni ·

  Yahoo
  Revolution Medicines Announces FDA Breakthrough Therapy Designation for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer with KRAS G12 Mutations
• 20 juni ·

  Yahoo
  This Revolution Medicines Insider Increased Their Holding In The Last Year